本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Travere Therapeutics, Inc.

21.15
+0.39001.88%
盘后21.150.00000.00%16:20 EDT
成交量:233.38万
成交额:4,890.40万
市值:18.78亿
市盈率:-5.19
高:21.71
开:21.09
低:20.15
收:20.76
数据加载中...
2024/09/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

重要事件披露

Form 8-K - Current report
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

重要事件披露

Form 8-K - Current report
2024/06/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/13

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/05/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/24

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/20

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]